Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||
| Cash from operating activities | 386.03%71.22M | 85.55%-24.9M | -38,354.24%-172.28M | -100.56%-448K | 79.57M |
| Net profit before non-cash adjustment | -324.06%-52.24M | 113.59%23.32M | -101.51%-171.6M | -265.55%-85.16M | --51.44M |
| Total adjustment of non-cash items | 149.16%79.06M | -10.78%31.73M | 21.67%35.57M | 42.44%29.23M | --20.52M |
| -Depreciation and amortization | 239.38%85.43M | 51.49%25.17M | 83.49%16.62M | 93.34%9.06M | --4.68M |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | --3.62M |
| -Disposal profit | ---- | ---- | ---- | 140.54%10.69M | --4.45M |
| -Other non-cash items | -197.21%-6.37M | -65.39%6.56M | 99.83%18.95M | 22.00%9.48M | --7.77M |
| Changes in working capital | 155.54%44.4M | -120.61%-79.94M | -165.32%-36.24M | 628.87%55.47M | --7.61M |
| -Change in receivables | 186.12%34.19M | -174.16%-39.7M | 169.55%53.54M | -1,610.79%-76.98M | --5.1M |
| -Change in inventory | 188.32%42.88M | 8.21%-48.55M | -403.66%-52.89M | 125.35%17.42M | ---68.72M |
| -Change in payables | -159.11%-21.33M | 216.37%36.08M | -207.04%-31M | -52.86%28.96M | --61.44M |
| -Changes in other current assets | 222.49%32.25M | -722.24%-26.33M | -120.04%-3.2M | 159.00%15.98M | ---27.09M |
| -Changes in other current liabilities | -2,931.85%-43.6M | 46.24%-1.44M | -103.82%-2.68M | 90.04%70.09M | --36.88M |
| Dividends paid (cash flow from operating activities) | |||||
| Dividends received (cash flow from operating activities) | |||||
| Interest paid (cash flow from operating activities) | -1,812.44%-8.61M | -36.36%-450K | 65.70%-330K | 14.41%-962K | -1.12M |
| Interest received (cash flow from operating activities) | 221K | 0 | 0 | 0 | 0 |
| Tax refund paid | -85.47%-16.15M | -181.36%-8.71M | 153.24%10.7M | -344.70%-20.1M | -4.52M |
| Other operating cash inflow (outflow) | -1K | 0 | 0 | 0 | 1K |
| Operating cash flow | 237.09%46.69M | 78.97%-34.06M | -652.84%-161.91M | -129.09%-21.51M | --73.93M |
| Investing cash flow | |||||
| Net PPE purchase and sale | -176,119.29%-794.75M | 96.48%-451K | -53.22%-12.82M | 26.87%-8.37M | ---11.44M |
| Net intangibles purchase and sale | 25.94%-65.92M | -116.80%-89.01M | -9.82%-41.06M | -164.34%-37.39M | ---14.14M |
| Net business purchase and sale | ---482.79M | ---- | ---- | ---- | ---5M |
| Net investment product transactions | ---- | ---- | ---- | ---- | ---1.2M |
| Net changes in other investments | ---- | -100.04%-1K | 29.60%2.4M | 106.17%1.86M | ---30.07M |
| Investing cash flow | -1,401.69%-1.34B | -73.82%-89.46M | -17.25%-51.47M | 29.02%-43.9M | ---61.85M |
| Financing cash flow | |||||
| Net issuance payments of debt | 1,886.62%1.33B | 199.72%66.86M | -59.12%-67.04M | -168.00%-42.13M | --61.96M |
| Net common stock issuance | 1,983.84%15.86M | -99.86%761K | -15.19%549.36M | --647.72M | --0 |
| Issuance fees | ---- | -430.40%-10.61M | ---2M | --0 | ---- |
| Net other fund-raising expenses | ---- | ---1K | ---- | ---- | ---- |
| Financing cash flow | 2,257.63%1.34B | -88.13%57.01M | -20.69%480.32M | 877.38%605.59M | --61.96M |
| Net cash flow | |||||
| Beginning cash position | -6.34%982.35M | 34.14%1.05B | 223.47%781.91M | 45.09%241.72M | --166.61M |
| Current changes in cash | 171.03%47.25M | -124.92%-66.51M | -50.58%266.95M | 629.55%540.19M | --74.04M |
| Effect of exchange rate changes | --0 | ---- | ---- | --0 | ---- |
| Cash adjustments other than cash changes | --1K | ---- | 0.00%-1K | -100.09%-1K | --1.07M |
| End cash Position | 4.81%1.03B | -6.34%982.35M | 34.14%1.05B | 223.47%781.91M | --241.72M |
| Free cash flow | -559.00%-813.98M | 42.76%-123.52M | -220.82%-215.78M | -239.11%-67.26M | --48.35M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |